Literature DB >> 18279074

Fibrosis and hypertrophy induced by Trypanosoma cruzi in a three-dimensional cardiomyocyte-culture system.

Luciana Ribeiro Garzoni1, Daniel Adesse, Maurilio José Soares, Maria Isabel Doria Rossi, Radovan Borojevic, Maria de Nazareth Leal de Meirelles.   

Abstract

Cardiac damages caused by in vivo infection with Trypanosoma cruzi are still not fully clarified. Here we describe for the first time an in vitro model of fibrosis, hypertrophy, and remodeling induced by T. cruzi in cardiomyocyte spheroids (cardiac microtissues). In this new 3-dimensional system, cardiac spheroids showed spontaneous contractility, with typical cardiac morphology and production of extracellular matrix components. There were 4- and 6-fold increases, respectively, in the area and the volume of T. cruzi-infected cardiomyocytes and whole microtissues, together with a 50% reduction of the cell population. Immunofluorescence showed increased expression of fibronectin, collagen IV, and laminin in the microtissues 144 h after infection. T. cruzi infection induced an increase in both the cellular area and the extracellular matrix components in cardiac spheroids, which contributed to an increase in total microtissue volume, making this a powerful 3-dimensional in vitro model for the study of cardiac-tissue hypertrophy, fibrosis, and remodeling.

Entities:  

Mesh:

Year:  2008        PMID: 18279074     DOI: 10.1086/528373

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Functional scaffold-free 3-D cardiac microtissues: a novel model for the investigation of heart cells.

Authors:  B R Desroches; P Zhang; B-R Choi; M E King; A E Maldonado; W Li; A Rago; G Liu; N Nath; K M Hartmann; B Yang; G Koren; J R Morgan; U Mende
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

2.  Inhibition of NFE2L2-Antioxidant Response Element Pathway by Mitochondrial Reactive Oxygen Species Contributes to Development of Cardiomyopathy and Left Ventricular Dysfunction in Chagas Disease.

Authors:  Jake Jianjun Wen; Craig Porter; Nisha Jain Garg
Journal:  Antioxid Redox Signal       Date:  2017-07-13       Impact factor: 8.401

Review 3.  Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance.

Authors:  Andrea Barison; Chrysanthos Grigoratos; Giancarlo Todiere; Giovanni Donato Aquaro
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

4.  Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas disease.

Authors:  Rafaelle Christine Gomes Fares; Juliana de Assis Silva Gomes; Luciana Ribeiro Garzoni; Mariana Caldas Waghabi; Roberto Magalhães Saraiva; Nayara Ingrid Medeiros; Roberta Oliveira-Prado; Luiz Henrique Conde Sangenis; Mayara da Costa Chambela; Fernanda Fortes de Araújo; Andréa Teixeira-Carvalho; Marcos Paulo Damásio; Vanessa Azevedo Valente; Karine Silvestre Ferreira; Giovane Rodrigo Sousa; Manoel Otávio da Costa Rocha; Rodrigo Correa-Oliveira
Journal:  Infect Immun       Date:  2013-07-15       Impact factor: 3.441

Review 5.  Central role of metabolism in Trypanosoma cruzi tropism and Chagas disease pathogenesis.

Authors:  Zongyuan Liu; Rebecca Ulrich vonBargen; Laura-Isobel McCall
Journal:  Curr Opin Microbiol       Date:  2021-08-26       Impact factor: 7.584

6.  Platelet polyphosphate induces fibroblast chemotaxis and myofibroblast differentiation.

Authors:  Patrick M Suess; Stephanie A Smith; James H Morrissey
Journal:  J Thromb Haemost       Date:  2020-09-10       Impact factor: 5.824

7.  Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy.

Authors:  Vanaja Konduri; Matthew M Halpert; Dan Liang; Jonathan M Levitt; Julio Vladimir Cruz-Chan; Bin Zhan; Maria Elena Bottazzi; Peter J Hotez; Kathryn M Jones; William K Decker
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

8.  Current understanding of the Trypanosoma cruzi-cardiomyocyte interaction.

Authors:  Claudia M Calvet; Tatiana G Melo; Luciana R Garzoni; Francisco O R Oliveira; Dayse T Silva Neto; Maria N S L; L Meirelles; Mirian C S Pereira
Journal:  Front Immunol       Date:  2012-10-30       Impact factor: 7.561

9.  Early Regulation of Profibrotic Genes in Primary Human Cardiac Myocytes by Trypanosoma cruzi.

Authors:  Aniekanabassi N Udoko; Candice A Johnson; Andrey Dykan; Girish Rachakonda; Fernando Villalta; Sammed N Mandape; Maria F Lima; Siddharth Pratap; Pius N Nde
Journal:  PLoS Negl Trop Dis       Date:  2016-01-15

10.  Trypanosoma cruzi activates mouse cardiac fibroblasts in vitro leading to fibroblast-myofibroblast transition and increase in expression of extracellular matrix proteins.

Authors:  Laura Lacerda Coelho; Isabela Resende Pereira; Mirian Claudia de Souza Pereira; Liliane Mesquita; Joseli Lannes-Vieira; Daniel Adesse; Luciana Ribeiro Garzoni
Journal:  Parasit Vectors       Date:  2018-01-30       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.